1737 related articles for article (PubMed ID: 16256090)
1. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
2. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
3. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
[TBL] [Abstract][Full Text] [Related]
4. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methods used for the determination of cholinesterase activity in whole blood.
Naik RS; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
7. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
8. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
[TBL] [Abstract][Full Text] [Related]
9. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
10. Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults.
Morasch KC; Aaron CL; Moon JE; Gordon RK
Physiol Behav; 2015 Jan; 138():165-72. PubMed ID: 25455867
[TBL] [Abstract][Full Text] [Related]
11. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a simple assay for the determination of cholinesterase activity in whole blood of laboratory animals.
Naik RS; Liu W; Saxena A
J Appl Toxicol; 2013 Apr; 33(4):290-300. PubMed ID: 22407886
[TBL] [Abstract][Full Text] [Related]
13. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
Eckert S; Eyer P; Worek F
Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
[TBL] [Abstract][Full Text] [Related]
15. [+]-Huperzine A protects against soman toxicity in guinea pigs.
Wang Y; Wei Y; Oguntayo S; Jensen N; Doctor BP; Nambiar MP
Neurochem Res; 2011 Dec; 36(12):2381-90. PubMed ID: 21822920
[TBL] [Abstract][Full Text] [Related]
16. Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity.
Lallement G; Demoncheaux JP; Foquin A; Baubichon D; Galonnier M; Clarençon D; Dorandeu F
Drug Chem Toxicol; 2002 Aug; 25(3):309-20. PubMed ID: 12173251
[TBL] [Abstract][Full Text] [Related]
17. A combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in guinea pigs.
Wang Y; Wei Y; Oguntayo S; Doctor BP; Nambiar MP
Chem Biol Interact; 2013 Mar; 203(1):120-4. PubMed ID: 23123250
[TBL] [Abstract][Full Text] [Related]
18. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of an insect repellent, N,N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats.
Chaney LA; Wineman RW; Rockhold RW; Hume AS
Toxicol Appl Pharmacol; 2000 Jun; 165(2):107-14. PubMed ID: 10828206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
